General Information of Drug Transporter (DT)
DT ID DTD0126 Transporter Info
Gene Name SLC19A1
Transporter Name Folate transporter 1
Gene ID
6573
UniProt ID
P41440
Epigenetic Regulations of This DT (EGR)

Methylation

  Atypical teratoid rhabdoid tumor

         11 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC19A1 in atypical teratoid rhabdoid tumor [ 1 ]

Location

5'UTR (cg03721454)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.31E+00 Statistic Test p-value: 1.90E-08; Z-score: -1.44E+00

Methylation in Case

5.47E-01 (Median) Methylation in Control 7.17E-01 (Median)

Studied Phenotype

Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC19A1 in atypical teratoid rhabdoid tumor [ 1 ]

Location

5'UTR (cg06731865)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.37E+00 Statistic Test p-value: 6.96E-08; Z-score: 1.59E+00

Methylation in Case

7.54E-01 (Median) Methylation in Control 5.50E-01 (Median)

Studied Phenotype

Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC19A1 in atypical teratoid rhabdoid tumor [ 1 ]

Location

5'UTR (cg15725933)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.12E+00 Statistic Test p-value: 1.54E-06; Z-score: -1.15E+00

Methylation in Case

7.05E-01 (Median) Methylation in Control 7.88E-01 (Median)

Studied Phenotype

Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC19A1 in atypical teratoid rhabdoid tumor [ 1 ]

Location

5'UTR (cg18035534)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.47E+00 Statistic Test p-value: 2.28E-06; Z-score: 1.53E+00

Methylation in Case

7.29E-01 (Median) Methylation in Control 4.96E-01 (Median)

Studied Phenotype

Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 5

Methylation of SLC19A1 in atypical teratoid rhabdoid tumor [ 1 ]

Location

5'UTR (cg18353345)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.36E+00 Statistic Test p-value: 2.47E-06; Z-score: -1.02E+00

Methylation in Case

4.91E-01 (Median) Methylation in Control 6.66E-01 (Median)

Studied Phenotype

Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 6

Methylation of SLC19A1 in atypical teratoid rhabdoid tumor [ 1 ]

Location

Body (cg00714531)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.15E+00 Statistic Test p-value: 3.45E-05; Z-score: 4.68E-01

Methylation in Case

1.91E-01 (Median) Methylation in Control 1.66E-01 (Median)

Studied Phenotype

Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 7

Methylation of SLC19A1 in atypical teratoid rhabdoid tumor [ 1 ]

Location

Body (cg03031182)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.13E+00 Statistic Test p-value: 2.49E-04; Z-score: 7.86E-01

Methylation in Case

8.68E-01 (Median) Methylation in Control 7.68E-01 (Median)

Studied Phenotype

Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 8

Methylation of SLC19A1 in atypical teratoid rhabdoid tumor [ 1 ]

Location

Body (cg04307902)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -3.32E+00 Statistic Test p-value: 6.84E-04; Z-score: -3.54E-01

Methylation in Case

2.75E-02 (Median) Methylation in Control 9.11E-02 (Median)

Studied Phenotype

Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 9

Methylation of SLC19A1 in atypical teratoid rhabdoid tumor [ 1 ]

Location

Body (cg07844507)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.02E+00 Statistic Test p-value: 5.00E-03; Z-score: 5.35E-02

Methylation in Case

1.61E-01 (Median) Methylation in Control 1.57E-01 (Median)

Studied Phenotype

Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 10

Methylation of SLC19A1 in atypical teratoid rhabdoid tumor [ 1 ]

Location

Body (cg07996352)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.19E+00 Statistic Test p-value: 5.22E-03; Z-score: -9.30E-01

Methylation in Case

2.61E-01 (Median) Methylation in Control 3.10E-01 (Median)

Studied Phenotype

Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 11

Methylation of SLC19A1 in atypical teratoid rhabdoid tumor [ 1 ]

Location

3'UTR (cg22991943)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.31E+00 Statistic Test p-value: 7.61E-10; Z-score: -1.65E+00

Methylation in Case

5.60E-01 (Median) Methylation in Control 7.33E-01 (Median)

Studied Phenotype

Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y]

Experimental Material

Patient tissue samples

  Bladder cancer

         10 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC19A1 in bladder cancer [ 2 ]

Location

5'UTR (cg18035534)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.45E+00 Statistic Test p-value: 2.59E-09; Z-score: -1.99E+01

Methylation in Case

5.76E-01 (Median) Methylation in Control 8.37E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC19A1 in bladder cancer [ 2 ]

Location

5'UTR (cg03721454)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.25E+00 Statistic Test p-value: 6.77E-04; Z-score: 4.92E+00

Methylation in Case

6.57E-01 (Median) Methylation in Control 5.28E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC19A1 in bladder cancer [ 2 ]

Location

5'UTR (cg06731865)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.08E+00 Statistic Test p-value: 6.91E-04; Z-score: -3.04E+00

Methylation in Case

7.58E-01 (Median) Methylation in Control 8.18E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC19A1 in bladder cancer [ 2 ]

Location

TSS1500 (cg17243364)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.28E+00 Statistic Test p-value: 1.60E-07; Z-score: -7.42E+00

Methylation in Case

1.55E-01 (Median) Methylation in Control 1.99E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 5

Methylation of SLC19A1 in bladder cancer [ 2 ]

Location

TSS200 (cg10119313)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.48E+00 Statistic Test p-value: 1.82E-03; Z-score: -2.48E+00

Methylation in Case

3.51E-02 (Median) Methylation in Control 5.19E-02 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 6

Methylation of SLC19A1 in bladder cancer [ 2 ]

Location

TSS200 (cg11940663)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.33E+00 Statistic Test p-value: 3.80E-02; Z-score: -1.06E+00

Methylation in Case

3.20E-02 (Median) Methylation in Control 4.26E-02 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 7

Methylation of SLC19A1 in bladder cancer [ 2 ]

Location

Body (cg17803589)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.80E+00 Statistic Test p-value: 1.34E-10; Z-score: -1.14E+01

Methylation in Case

3.99E-01 (Median) Methylation in Control 7.18E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 8

Methylation of SLC19A1 in bladder cancer [ 2 ]

Location

Body (cg03031182)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.21E+00 Statistic Test p-value: 1.88E-06; Z-score: -6.58E+00

Methylation in Case

6.59E-01 (Median) Methylation in Control 7.97E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 9

Methylation of SLC19A1 in bladder cancer [ 2 ]

Location

Body (cg07844507)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.14E+00 Statistic Test p-value: 4.36E-06; Z-score: -5.09E+00

Methylation in Case

7.15E-01 (Median) Methylation in Control 8.17E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 10

Methylation of SLC19A1 in bladder cancer [ 2 ]

Location

Body (cg19074198)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.31E+00 Statistic Test p-value: 2.48E-05; Z-score: 4.92E+00

Methylation in Case

7.93E-01 (Median) Methylation in Control 6.05E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Breast cancer

         11 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC19A1 in breast cancer [ 3 ]

Location

5'UTR (cg06731865)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.04E+00 Statistic Test p-value: 1.03E-04; Z-score: -9.42E-01

Methylation in Case

8.03E-01 (Median) Methylation in Control 8.36E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC19A1 in breast cancer [ 3 ]

Location

5'UTR (cg03721454)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.14E+00 Statistic Test p-value: 9.75E-04; Z-score: 1.12E+00

Methylation in Case

4.86E-01 (Median) Methylation in Control 4.27E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC19A1 in breast cancer [ 3 ]

Location

5'UTR (cg18035534)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.03E+00 Statistic Test p-value: 9.93E-03; Z-score: -6.78E-01

Methylation in Case

8.57E-01 (Median) Methylation in Control 8.86E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC19A1 in breast cancer [ 3 ]

Location

5'UTR (cg18353345)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.06E+00 Statistic Test p-value: 2.20E-02; Z-score: -3.29E-01

Methylation in Case

7.76E-02 (Median) Methylation in Control 8.25E-02 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 5

Methylation of SLC19A1 in breast cancer [ 3 ]

Location

TSS1500 (cg07658590)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.42E+00 Statistic Test p-value: 1.35E-18; Z-score: 3.39E+00

Methylation in Case

5.86E-01 (Median) Methylation in Control 4.14E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 6

Methylation of SLC19A1 in breast cancer [ 3 ]

Location

TSS1500 (cg17243364)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.13E+00 Statistic Test p-value: 2.85E-03; Z-score: -9.74E-01

Methylation in Case

1.62E-01 (Median) Methylation in Control 1.84E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 7

Methylation of SLC19A1 in breast cancer [ 3 ]

Location

TSS200 (cg18108695)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.12E+00 Statistic Test p-value: 4.89E-02; Z-score: 2.49E-01

Methylation in Case

5.64E-02 (Median) Methylation in Control 5.02E-02 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 8

Methylation of SLC19A1 in breast cancer [ 3 ]

Location

Body (cg27368243)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.15E+00 Statistic Test p-value: 1.49E-03; Z-score: -1.42E+00

Methylation in Case

4.54E-01 (Median) Methylation in Control 5.23E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 9

Methylation of SLC19A1 in breast cancer [ 3 ]

Location

Body (cg07844507)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.03E+00 Statistic Test p-value: 1.30E-02; Z-score: 3.08E-01

Methylation in Case

7.83E-01 (Median) Methylation in Control 7.62E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 10

Methylation of SLC19A1 in breast cancer [ 3 ]

Location

Body (cg04307902)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.03E+00 Statistic Test p-value: 2.14E-02; Z-score: -6.75E-01

Methylation in Case

8.60E-01 (Median) Methylation in Control 8.90E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 11

Methylation of SLC19A1 in breast cancer [ 3 ]

Location

3'UTR (cg22991943)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.14E+00 Statistic Test p-value: 9.53E-08; Z-score: -1.87E+00

Methylation in Case

6.31E-01 (Median) Methylation in Control 7.21E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Renal cell carcinoma

           8 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC19A1 in clear cell renal cell carcinoma [ 4 ]

Location

5'UTR (cg18353345)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -3.29E+00 Statistic Test p-value: 8.06E-10; Z-score: -2.39E+00

Methylation in Case

6.73E-02 (Median) Methylation in Control 2.21E-01 (Median)

Studied Phenotype

Renal cell carcinoma [ ICD-11: 2C90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC19A1 in clear cell renal cell carcinoma [ 4 ]

Location

5'UTR (cg03721454)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.33E+00 Statistic Test p-value: 6.99E-07; Z-score: 3.19E+00

Methylation in Case

7.00E-01 (Median) Methylation in Control 5.27E-01 (Median)

Studied Phenotype

Renal cell carcinoma [ ICD-11: 2C90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC19A1 in clear cell renal cell carcinoma [ 4 ]

Location

5'UTR (cg06731865)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.04E+00 Statistic Test p-value: 1.04E-06; Z-score: -2.54E+00

Methylation in Case

9.02E-01 (Median) Methylation in Control 9.37E-01 (Median)

Studied Phenotype

Renal cell carcinoma [ ICD-11: 2C90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC19A1 in clear cell renal cell carcinoma [ 4 ]

Location

TSS1500 (cg21279603)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.08E+00 Statistic Test p-value: 2.81E-08; Z-score: -1.58E+00

Methylation in Case

8.23E-01 (Median) Methylation in Control 8.88E-01 (Median)

Studied Phenotype

Renal cell carcinoma [ ICD-11: 2C90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 5

Methylation of SLC19A1 in clear cell renal cell carcinoma [ 4 ]

Location

Body (cg27368243)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.14E+00 Statistic Test p-value: 1.12E-06; Z-score: -1.51E+00

Methylation in Case

7.14E-01 (Median) Methylation in Control 8.16E-01 (Median)

Studied Phenotype

Renal cell carcinoma [ ICD-11: 2C90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 6

Methylation of SLC19A1 in clear cell renal cell carcinoma [ 4 ]

Location

Body (cg07844507)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.02E+00 Statistic Test p-value: 3.90E-05; Z-score: -1.38E+00

Methylation in Case

9.40E-01 (Median) Methylation in Control 9.56E-01 (Median)

Studied Phenotype

Renal cell carcinoma [ ICD-11: 2C90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 7

Methylation of SLC19A1 in clear cell renal cell carcinoma [ 4 ]

Location

Body (cg03031182)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.23E+00 Statistic Test p-value: 2.96E-03; Z-score: 2.74E+00

Methylation in Case

8.74E-01 (Median) Methylation in Control 7.09E-01 (Median)

Studied Phenotype

Renal cell carcinoma [ ICD-11: 2C90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 8

Methylation of SLC19A1 in clear cell renal cell carcinoma [ 4 ]

Location

Body (cg16071082)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.00E+00 Statistic Test p-value: 1.17E-02; Z-score: -4.74E-01

Methylation in Case

9.70E-01 (Median) Methylation in Control 9.73E-01 (Median)

Studied Phenotype

Renal cell carcinoma [ ICD-11: 2C90]

Experimental Material

Patient tissue samples

  Colon cancer

           8 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC19A1 in colon adenocarcinoma [ 5 ]

Location

5'UTR (cg14393466)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.10E+00 Statistic Test p-value: 1.75E-03; Z-score: -1.86E+00

Methylation in Case

6.84E-01 (Median) Methylation in Control 7.55E-01 (Median)

Studied Phenotype

Colon cancer [ ICD-11: 2B90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC19A1 in colon adenocarcinoma [ 5 ]

Location

TSS1500 (cg04592728)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.61E+00 Statistic Test p-value: 1.34E-06; Z-score: 3.68E+00

Methylation in Case

5.61E-01 (Median) Methylation in Control 3.48E-01 (Median)

Studied Phenotype

Colon cancer [ ICD-11: 2B90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC19A1 in colon adenocarcinoma [ 5 ]

Location

TSS200 (cg03929977)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 2.24E+00 Statistic Test p-value: 5.60E-08; Z-score: 3.88E+00

Methylation in Case

5.03E-01 (Median) Methylation in Control 2.25E-01 (Median)

Studied Phenotype

Colon cancer [ ICD-11: 2B90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC19A1 in colon adenocarcinoma [ 5 ]

Location

TSS200 (cg25811526)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.36E+00 Statistic Test p-value: 1.09E-06; Z-score: -3.93E+00

Methylation in Case

3.88E-01 (Median) Methylation in Control 5.29E-01 (Median)

Studied Phenotype

Colon cancer [ ICD-11: 2B90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 5

Methylation of SLC19A1 in colon adenocarcinoma [ 5 ]

Location

1stExon (cg05063104)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.22E+00 Statistic Test p-value: 4.87E-04; Z-score: 1.98E+00

Methylation in Case

4.92E-01 (Median) Methylation in Control 4.03E-01 (Median)

Studied Phenotype

Colon cancer [ ICD-11: 2B90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 6

Methylation of SLC19A1 in colon adenocarcinoma [ 5 ]

Location

Body (cg12461092)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.45E+00 Statistic Test p-value: 2.68E-07; Z-score: -5.63E+00

Methylation in Case

4.57E-01 (Median) Methylation in Control 6.64E-01 (Median)

Studied Phenotype

Colon cancer [ ICD-11: 2B90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 7

Methylation of SLC19A1 in colon adenocarcinoma [ 5 ]

Location

Body (cg25822376)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.32E+00 Statistic Test p-value: 1.36E-06; Z-score: -3.08E+00

Methylation in Case

5.36E-01 (Median) Methylation in Control 7.08E-01 (Median)

Studied Phenotype

Colon cancer [ ICD-11: 2B90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 8

Methylation of SLC19A1 in colon adenocarcinoma [ 5 ]

Location

Body (cg04470085)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.14E+00 Statistic Test p-value: 1.84E-05; Z-score: -5.56E+00

Methylation in Case

7.25E-01 (Median) Methylation in Control 8.28E-01 (Median)

Studied Phenotype

Colon cancer [ ICD-11: 2B90]

Experimental Material

Patient tissue samples

  Colorectal cancer

         13 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC19A1 in colorectal cancer [ 6 ]

Location

5'UTR (cg06731865)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.02E+00 Statistic Test p-value: 5.12E-08; Z-score: -1.78E+00

Methylation in Case

8.95E-01 (Median) Methylation in Control 9.16E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC19A1 in colorectal cancer [ 6 ]

Location

5'UTR (cg15725933)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.14E+00 Statistic Test p-value: 2.59E-02; Z-score: 6.30E-01

Methylation in Case

3.78E-02 (Median) Methylation in Control 3.31E-02 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC19A1 in colorectal cancer [ 6 ]

Location

TSS1500 (cg17243364)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.29E+00 Statistic Test p-value: 5.41E-07; Z-score: 1.62E+00

Methylation in Case

2.64E-01 (Median) Methylation in Control 2.05E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC19A1 in colorectal cancer [ 6 ]

Location

TSS1500 (cg21279603)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.05E+00 Statistic Test p-value: 1.16E-06; Z-score: -1.71E+00

Methylation in Case

8.48E-01 (Median) Methylation in Control 8.94E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 5

Methylation of SLC19A1 in colorectal cancer [ 6 ]

Location

TSS1500 (cg07658590)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.09E+00 Statistic Test p-value: 1.12E-03; Z-score: -1.01E+00

Methylation in Case

7.34E-01 (Median) Methylation in Control 7.98E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 6

Methylation of SLC19A1 in colorectal cancer [ 6 ]

Location

TSS200 (cg18108695)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.34E+00 Statistic Test p-value: 1.32E-04; Z-score: 1.29E+00

Methylation in Case

3.75E-02 (Median) Methylation in Control 2.81E-02 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 7

Methylation of SLC19A1 in colorectal cancer [ 6 ]

Location

TSS200 (cg10119313)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.12E+00 Statistic Test p-value: 3.80E-03; Z-score: 4.29E-01

Methylation in Case

2.58E-02 (Median) Methylation in Control 2.30E-02 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 8

Methylation of SLC19A1 in colorectal cancer [ 6 ]

Location

Body (cg19074198)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.20E+00 Statistic Test p-value: 2.17E-05; Z-score: 1.42E+00

Methylation in Case

8.68E-01 (Median) Methylation in Control 7.24E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 9

Methylation of SLC19A1 in colorectal cancer [ 6 ]

Location

Body (cg07844507)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.02E+00 Statistic Test p-value: 1.09E-04; Z-score: -9.80E-01

Methylation in Case

9.16E-01 (Median) Methylation in Control 9.32E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 10

Methylation of SLC19A1 in colorectal cancer [ 6 ]

Location

Body (cg27368243)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.05E+00 Statistic Test p-value: 3.31E-02; Z-score: -4.99E-01

Methylation in Case

7.66E-01 (Median) Methylation in Control 8.07E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 11

Methylation of SLC19A1 in colorectal cancer [ 6 ]

Location

Body (cg04307902)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.00E+00 Statistic Test p-value: 4.99E-02; Z-score: -1.63E-01

Methylation in Case

9.41E-01 (Median) Methylation in Control 9.43E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 12

Methylation of SLC19A1 in colorectal cancer [ 6 ]

Location

3'UTR (cg22991943)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.00E+00 Statistic Test p-value: 1.05E-02; Z-score: -3.37E-01

Methylation in Case

9.11E-01 (Median) Methylation in Control 9.15E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 13

Hypermethylation of SLC19A1 in colorectal cancer [ 18 ]

Location

Promoter

Epigenetic Type

Methylation Experiment Method Methylation-specific PCR

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Frequency

33 (78%) out of the 42 studied tumor samples

Experimental Material

Patient tissue samples

Additional Notes

SLC19A1 promoter Hypermethylation contribute to the occurrence and metastasis of CRC.

  Depression

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC19A1 in depression [ 7 ]

Location

5'UTR (cg18353345)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.07E+00 Statistic Test p-value: 1.60E-02; Z-score: -6.74E-01

Methylation in Case

7.15E-02 (Median) Methylation in Control 7.68E-02 (Median)

Studied Phenotype

Depression [ ICD-11: 6A8Z]

Experimental Material

Patient tissue samples

  Hepatocellular carcinoma

         12 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC19A1 in hepatocellular carcinoma [ 8 ]

Location

5'UTR (cg03721454)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.01E+00 Statistic Test p-value: 4.30E-02; Z-score: -1.35E-01

Methylation in Case

6.99E-01 (Median) Methylation in Control 7.05E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC19A1 in hepatocellular carcinoma [ 8 ]

Location

TSS200 (cg02203420)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.65E+00 Statistic Test p-value: 3.96E-20; Z-score: -6.83E+00

Methylation in Case

4.66E-01 (Median) Methylation in Control 7.70E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC19A1 in hepatocellular carcinoma [ 8 ]

Location

TSS200 (cg22149516)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 2.55E+00 Statistic Test p-value: 6.67E-10; Z-score: 5.60E+00

Methylation in Case

2.76E-01 (Median) Methylation in Control 1.08E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC19A1 in hepatocellular carcinoma [ 8 ]

Location

Body (cg23462788)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.80E+00 Statistic Test p-value: 1.99E-22; Z-score: -9.81E+00

Methylation in Case

4.52E-01 (Median) Methylation in Control 8.14E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 5

Methylation of SLC19A1 in hepatocellular carcinoma [ 8 ]

Location

Body (cg02641517)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.85E+00 Statistic Test p-value: 3.04E-17; Z-score: -4.02E+00

Methylation in Case

3.68E-01 (Median) Methylation in Control 6.82E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 6

Methylation of SLC19A1 in hepatocellular carcinoma [ 8 ]

Location

Body (cg07806361)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.41E+00 Statistic Test p-value: 2.47E-14; Z-score: -4.85E+00

Methylation in Case

5.53E-01 (Median) Methylation in Control 7.79E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 7

Methylation of SLC19A1 in hepatocellular carcinoma [ 8 ]

Location

Body (cg14310831)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.28E+00 Statistic Test p-value: 4.06E-11; Z-score: -1.72E+00

Methylation in Case

5.99E-01 (Median) Methylation in Control 7.68E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 8

Methylation of SLC19A1 in hepatocellular carcinoma [ 8 ]

Location

Body (cg27368243)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.13E+00 Statistic Test p-value: 8.89E-05; Z-score: 7.13E-01

Methylation in Case

5.38E-01 (Median) Methylation in Control 4.75E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 9

Methylation of SLC19A1 in hepatocellular carcinoma [ 8 ]

Location

Body (cg03031182)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.00E+00 Statistic Test p-value: 5.16E-03; Z-score: -2.24E-01

Methylation in Case

8.53E-01 (Median) Methylation in Control 8.56E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 10

Methylation of SLC19A1 in hepatocellular carcinoma [ 8 ]

Location

Body (cg17803589)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.03E+00 Statistic Test p-value: 1.37E-02; Z-score: 4.55E-01

Methylation in Case

8.12E-01 (Median) Methylation in Control 7.89E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 11

Methylation of SLC19A1 in hepatocellular carcinoma [ 8 ]

Location

Body (cg07844507)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.01E+00 Statistic Test p-value: 1.38E-02; Z-score: 4.87E-01

Methylation in Case

8.34E-01 (Median) Methylation in Control 8.22E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 12

Methylation of SLC19A1 in hepatocellular carcinoma [ 8 ]

Location

Body (cg00714531)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.04E+00 Statistic Test p-value: 3.35E-02; Z-score: 2.10E-01

Methylation in Case

8.49E-01 (Median) Methylation in Control 8.19E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  HIV infection

           8 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC19A1 in HIV infection [ 9 ]

Location

5'UTR (cg06731865)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.18E+00 Statistic Test p-value: 1.31E-10; Z-score: 3.30E+00

Methylation in Case

7.70E-01 (Median) Methylation in Control 6.54E-01 (Median)

Studied Phenotype

HIV infection [ ICD-11: 1C62.Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC19A1 in HIV infection [ 9 ]

Location

TSS1500 (cg21279603)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.17E+00 Statistic Test p-value: 4.62E-12; Z-score: 2.36E+00

Methylation in Case

7.31E-01 (Median) Methylation in Control 6.26E-01 (Median)

Studied Phenotype

HIV infection [ ICD-11: 1C62.Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC19A1 in HIV infection [ 9 ]

Location

TSS1500 (cg07658590)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.35E+00 Statistic Test p-value: 2.73E-11; Z-score: 2.94E+00

Methylation in Case

6.06E-01 (Median) Methylation in Control 4.49E-01 (Median)

Studied Phenotype

HIV infection [ ICD-11: 1C62.Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC19A1 in HIV infection [ 9 ]

Location

TSS1500 (cg17243364)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.22E+00 Statistic Test p-value: 8.53E-07; Z-score: 1.50E+00

Methylation in Case

2.11E-01 (Median) Methylation in Control 1.73E-01 (Median)

Studied Phenotype

HIV infection [ ICD-11: 1C62.Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 5

Methylation of SLC19A1 in HIV infection [ 9 ]

Location

Body (cg00714531)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.05E+00 Statistic Test p-value: 4.00E-08; Z-score: 1.37E+00

Methylation in Case

9.07E-01 (Median) Methylation in Control 8.60E-01 (Median)

Studied Phenotype

HIV infection [ ICD-11: 1C62.Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 6

Methylation of SLC19A1 in HIV infection [ 9 ]

Location

Body (cg07844507)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.07E+00 Statistic Test p-value: 1.33E-07; Z-score: 1.62E+00

Methylation in Case

7.97E-01 (Median) Methylation in Control 7.45E-01 (Median)

Studied Phenotype

HIV infection [ ICD-11: 1C62.Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 7

Methylation of SLC19A1 in HIV infection [ 9 ]

Location

Body (cg27368243)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.29E+00 Statistic Test p-value: 1.95E-05; Z-score: 2.12E+00

Methylation in Case

3.77E-01 (Median) Methylation in Control 2.92E-01 (Median)

Studied Phenotype

HIV infection [ ICD-11: 1C62.Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 8

Methylation of SLC19A1 in HIV infection [ 9 ]

Location

Body (cg19074198)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.01E+00 Statistic Test p-value: 1.43E-03; Z-score: 4.92E-01

Methylation in Case

8.74E-01 (Median) Methylation in Control 8.63E-01 (Median)

Studied Phenotype

HIV infection [ ICD-11: 1C62.Z]

Experimental Material

Patient tissue samples

  Lung adenocarcinoma

           6 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC19A1 in lung adenocarcinoma [ 10 ]

Location

5'UTR (cg18353345)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.36E+00 Statistic Test p-value: 2.41E-03; Z-score: -1.50E+00

Methylation in Case

1.72E-01 (Median) Methylation in Control 2.34E-01 (Median)

Studied Phenotype

Lung adenocarcinoma [ ICD-11: 2C25.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC19A1 in lung adenocarcinoma [ 10 ]

Location

5'UTR (cg03721454)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.19E+00 Statistic Test p-value: 1.32E-02; Z-score: 1.48E+00

Methylation in Case

7.55E-01 (Median) Methylation in Control 6.37E-01 (Median)

Studied Phenotype

Lung adenocarcinoma [ ICD-11: 2C25.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC19A1 in lung adenocarcinoma [ 10 ]

Location

TSS1500 (cg07658590)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.21E+00 Statistic Test p-value: 1.61E-03; Z-score: 4.09E+00

Methylation in Case

6.41E-01 (Median) Methylation in Control 5.30E-01 (Median)

Studied Phenotype

Lung adenocarcinoma [ ICD-11: 2C25.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC19A1 in lung adenocarcinoma [ 10 ]

Location

Body (cg19074198)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.11E+00 Statistic Test p-value: 5.63E-03; Z-score: 2.00E+00

Methylation in Case

8.19E-01 (Median) Methylation in Control 7.39E-01 (Median)

Studied Phenotype

Lung adenocarcinoma [ ICD-11: 2C25.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 5

Methylation of SLC19A1 in lung adenocarcinoma [ 10 ]

Location

Body (cg00714531)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.04E+00 Statistic Test p-value: 3.31E-02; Z-score: 1.13E+00

Methylation in Case

9.06E-01 (Median) Methylation in Control 8.75E-01 (Median)

Studied Phenotype

Lung adenocarcinoma [ ICD-11: 2C25.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 6

Methylation of SLC19A1 in lung adenocarcinoma [ 10 ]

Location

Body (cg27368243)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.07E+00 Statistic Test p-value: 4.55E-02; Z-score: -1.14E+00

Methylation in Case

5.94E-01 (Median) Methylation in Control 6.36E-01 (Median)

Studied Phenotype

Lung adenocarcinoma [ ICD-11: 2C25.0]

Experimental Material

Patient tissue samples

  Panic disorder

           2 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC19A1 in panic disorder [ 11 ]

Location

5'UTR (cg15725933)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -9.90E-01 Statistic Test p-value: 4.80E-02; Z-score: -3.03E-01

Methylation in Case

-5.53E+00 (Median) Methylation in Control -5.47E+00 (Median)

Studied Phenotype

Panic disorder [ ICD-11: 6B01]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC19A1 in panic disorder [ 11 ]

Location

TSS1500 (cg07658590)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -8.04E-01 Statistic Test p-value: 5.68E-03; Z-score: -5.32E-01

Methylation in Case

-9.11E-01 (Median) Methylation in Control -7.33E-01 (Median)

Studied Phenotype

Panic disorder [ ICD-11: 6B01]

Experimental Material

Patient tissue samples

  Papillary thyroid cancer

         12 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC19A1 in papillary thyroid cancer [ 12 ]

Location

5'UTR (cg03721454)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.12E+00 Statistic Test p-value: 2.19E-07; Z-score: 1.64E+00

Methylation in Case

7.74E-01 (Median) Methylation in Control 6.90E-01 (Median)

Studied Phenotype

Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC19A1 in papillary thyroid cancer [ 12 ]

Location

5'UTR (cg18353345)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.31E+00 Statistic Test p-value: 2.08E-05; Z-score: -9.67E-01

Methylation in Case

1.25E-01 (Median) Methylation in Control 1.63E-01 (Median)

Studied Phenotype

Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC19A1 in papillary thyroid cancer [ 12 ]

Location

5'UTR (cg06731865)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.01E+00 Statistic Test p-value: 7.26E-03; Z-score: -6.25E-01

Methylation in Case

9.12E-01 (Median) Methylation in Control 9.22E-01 (Median)

Studied Phenotype

Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC19A1 in papillary thyroid cancer [ 12 ]

Location

5'UTR (cg15725933)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.07E+00 Statistic Test p-value: 2.10E-02; Z-score: -5.95E-01

Methylation in Case

7.70E-02 (Median) Methylation in Control 8.22E-02 (Median)

Studied Phenotype

Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 5

Methylation of SLC19A1 in papillary thyroid cancer [ 12 ]

Location

TSS1500 (cg17243364)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.14E+00 Statistic Test p-value: 6.01E-06; Z-score: -8.12E-01

Methylation in Case

1.61E-01 (Median) Methylation in Control 1.83E-01 (Median)

Studied Phenotype

Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 6

Methylation of SLC19A1 in papillary thyroid cancer [ 12 ]

Location

TSS1500 (cg21279603)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.01E+00 Statistic Test p-value: 3.15E-03; Z-score: -4.04E-01

Methylation in Case

8.04E-01 (Median) Methylation in Control 8.15E-01 (Median)

Studied Phenotype

Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 7

Methylation of SLC19A1 in papillary thyroid cancer [ 12 ]

Location

Body (cg00714531)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.01E+00 Statistic Test p-value: 3.74E-06; Z-score: -1.06E+00

Methylation in Case

9.46E-01 (Median) Methylation in Control 9.57E-01 (Median)

Studied Phenotype

Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 8

Methylation of SLC19A1 in papillary thyroid cancer [ 12 ]

Location

Body (cg25310447)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.01E+00 Statistic Test p-value: 1.14E-03; Z-score: -7.98E-01

Methylation in Case

9.34E-01 (Median) Methylation in Control 9.41E-01 (Median)

Studied Phenotype

Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 9

Methylation of SLC19A1 in papillary thyroid cancer [ 12 ]

Location

Body (cg07996352)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.01E+00 Statistic Test p-value: 5.00E-03; Z-score: -4.16E-01

Methylation in Case

9.12E-01 (Median) Methylation in Control 9.18E-01 (Median)

Studied Phenotype

Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 10

Methylation of SLC19A1 in papillary thyroid cancer [ 12 ]

Location

Body (cg27368243)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.02E+00 Statistic Test p-value: 1.58E-02; Z-score: -2.47E-01

Methylation in Case

7.56E-01 (Median) Methylation in Control 7.72E-01 (Median)

Studied Phenotype

Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 11

Methylation of SLC19A1 in papillary thyroid cancer [ 12 ]

Location

Body (cg07844507)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.00E+00 Statistic Test p-value: 1.60E-02; Z-score: -1.64E-01

Methylation in Case

8.98E-01 (Median) Methylation in Control 9.01E-01 (Median)

Studied Phenotype

Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 12

Methylation of SLC19A1 in papillary thyroid cancer [ 12 ]

Location

3'UTR (cg22991943)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.02E+00 Statistic Test p-value: 1.46E-02; Z-score: -6.77E-01

Methylation in Case

8.55E-01 (Median) Methylation in Control 8.69E-01 (Median)

Studied Phenotype

Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

Patient tissue samples

  Pancretic ductal adenocarcinoma

         10 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC19A1 in pancretic ductal adenocarcinoma [ 13 ]

Location

TSS1500 (cg06517489)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.02E+00 Statistic Test p-value: 8.14E-07; Z-score: 7.60E-02

Methylation in Case

1.19E-01 (Median) Methylation in Control 1.17E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC19A1 in pancretic ductal adenocarcinoma [ 13 ]

Location

TSS1500 (cg06746492)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.01E+00 Statistic Test p-value: 1.10E-04; Z-score: -3.24E-01

Methylation in Case

8.21E-01 (Median) Methylation in Control 8.31E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC19A1 in pancretic ductal adenocarcinoma [ 13 ]

Location

TSS1500 (cg04690729)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.00E+00 Statistic Test p-value: 2.44E-02; Z-score: -8.26E-03

Methylation in Case

7.89E-01 (Median) Methylation in Control 7.89E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC19A1 in pancretic ductal adenocarcinoma [ 13 ]

Location

1stExon (cg14930075)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 5.55E+00 Statistic Test p-value: 5.14E-29; Z-score: 5.42E+00

Methylation in Case

4.37E-01 (Median) Methylation in Control 7.88E-02 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 5

Methylation of SLC19A1 in pancretic ductal adenocarcinoma [ 13 ]

Location

1stExon (cg07726085)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.10E+00 Statistic Test p-value: 5.99E-05; Z-score: 1.31E+00

Methylation in Case

8.06E-01 (Median) Methylation in Control 7.32E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 6

Methylation of SLC19A1 in pancretic ductal adenocarcinoma [ 13 ]

Location

Body (cg23867721)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.10E+00 Statistic Test p-value: 3.67E-04; Z-score: 1.34E+00

Methylation in Case

6.51E-01 (Median) Methylation in Control 5.94E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 7

Methylation of SLC19A1 in pancretic ductal adenocarcinoma [ 13 ]

Location

Body (cg01554951)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.01E+00 Statistic Test p-value: 2.03E-03; Z-score: 8.53E-01

Methylation in Case

8.85E-01 (Median) Methylation in Control 8.72E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 8

Methylation of SLC19A1 in pancretic ductal adenocarcinoma [ 13 ]

Location

Body (cg21388745)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.05E+00 Statistic Test p-value: 3.03E-03; Z-score: 9.69E-01

Methylation in Case

8.56E-01 (Median) Methylation in Control 8.15E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 9

Methylation of SLC19A1 in pancretic ductal adenocarcinoma [ 13 ]

Location

Body (cg14315842)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.04E+00 Statistic Test p-value: 7.03E-03; Z-score: 6.27E-01

Methylation in Case

8.26E-01 (Median) Methylation in Control 7.93E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 10

Methylation of SLC19A1 in pancretic ductal adenocarcinoma [ 13 ]

Location

3'UTR (cg06535968)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.02E+00 Statistic Test p-value: 7.57E-03; Z-score: -3.58E-01

Methylation in Case

7.86E-01 (Median) Methylation in Control 8.02E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Celiac disease

           2 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC19A1 in celiac disease [ 14 ]

Location

Body (cg19074198)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.29E+00 Statistic Test p-value: 3.82E-03; Z-score: 1.09E+00

Methylation in Case

8.21E-01 (Median) Methylation in Control 6.35E-01 (Median)

Studied Phenotype

Celiac disease [ ICD-11: DA95]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC19A1 in celiac disease [ 14 ]

Location

Body (cg27368243)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.46E+00 Statistic Test p-value: 4.74E-03; Z-score: -1.24E+00

Methylation in Case

4.74E-01 (Median) Methylation in Control 6.94E-01 (Median)

Studied Phenotype

Celiac disease [ ICD-11: DA95]

Experimental Material

Patient tissue samples

  Prostate cancer

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC19A1 in prostate cancer [ 15 ]

Location

Body (cg26961166)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.79E+00 Statistic Test p-value: 5.02E-03; Z-score: -1.67E+01

Methylation in Case

2.57E-01 (Median) Methylation in Control 4.59E-01 (Median)

Studied Phenotype

Prostate cancer [ ICD-11: 2C82]

Experimental Material

Patient tissue samples

  Systemic lupus erythematosus

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC19A1 in systemic lupus erythematosus [ 16 ]

Location

Body (cg07996352)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.00E+00 Statistic Test p-value: 4.71E-02; Z-score: -2.27E-01

Methylation in Case

9.06E-01 (Median) Methylation in Control 9.10E-01 (Median)

Studied Phenotype

Systemic lupus erythematosus [ ICD-11: 4A40.0]

Experimental Material

Patient tissue samples

microRNA

  B-cell acute lymphoblastic leukemia

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

miR-595 downregulates SLC19A1 in B-cell acute lymphoblastic leukemia [ 17 ]

Epigenetic Type

microRNA Experiment Method Microarray

Related Molecular Changes

Down regulation of SLC19A1 Experiment Method Microarrays

miRNA Stemloop ID

miR-595 miRNA Mature ID miR-595

miRNA Sequence

GAAGUGUGCCGUGGUGUGUCU

miRNA Target Type

Direct

Studied Phenotype

B-cell acute lymphoblastic leukemia [ ICD-11: 2A82]

Experimental Material

Patient tissue samples

Additional Notes

SNPs in miR-595 that might affect SLC19A1 MTX transport gene regulation and could affect MTX levels in patients with pediatric B-cell ALL.

  Unclear Phenotype

           9 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

miR-125b directly targets SLC19A1 [ 19 ]

Epigenetic Type

microRNA Experiment Method CLASH

miRNA Stemloop ID

miR-125b miRNA Mature ID miR-125b-5p

miRNA Sequence

UCCCUGAGACCCUAACUUGUGA

miRNA Target Type

Direct

Experimental Material

Human embryonic kidney 293 cells (HEK293)

  Epigenetic Phenomenon 2

miR-16 directly targets SLC19A1 [ 19 ]

Epigenetic Type

microRNA Experiment Method CLASH

miRNA Stemloop ID

miR-16 miRNA Mature ID miR-16-5p

miRNA Sequence

UAGCAGCACGUAAAUAUUGGCG

miRNA Target Type

Direct

Experimental Material

Human embryonic kidney 293 cells (HEK293)

  Epigenetic Phenomenon 3

miR-3613 directly targets SLC19A1 [ 20 ]

Epigenetic Type

microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

miR-3613 miRNA Mature ID miR-3613-3p

miRNA Sequence

ACAAAAAAAAAAGCCCAACCCUUC

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 4

miR-4422 directly targets SLC19A1 [ 20 ]

Epigenetic Type

microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

miR-4422 miRNA Mature ID miR-4422

miRNA Sequence

AAAAGCAUCAGGAAGUACCCA

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 5

miR-4668 directly targets SLC19A1 [ 20 ]

Epigenetic Type

microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

miR-4668 miRNA Mature ID miR-4668-5p

miRNA Sequence

AGGGAAAAAAAAAAGGAUUUGUC

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 6

miR-484 directly targets SLC19A1 [ 19 ]

Epigenetic Type

microRNA Experiment Method CLASH

miRNA Stemloop ID

miR-484 miRNA Mature ID miR-484

miRNA Sequence

UCAGGCUCAGUCCCCUCCCGAU

miRNA Target Type

Direct

Experimental Material

Human embryonic kidney 293 cells (HEK293)

  Epigenetic Phenomenon 7

miR-548e directly targets SLC19A1 [ 20 ]

Epigenetic Type

microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

miR-548e miRNA Mature ID miR-548e-5p

miRNA Sequence

CAAAAGCAAUCGCGGUUUUUGC

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 8

miR-607 directly targets SLC19A1 [ 20 ]

Epigenetic Type

microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

miR-607 miRNA Mature ID miR-607

miRNA Sequence

GUUCAAAUCCAGAUCUAUAAC

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 9

miR-93 directly targets SLC19A1 [ 19 ]

Epigenetic Type

microRNA Experiment Method CLASH

miRNA Stemloop ID

miR-93 miRNA Mature ID miR-93-5p

miRNA Sequence

CAAAGUGCUGUUCGUGCAGGUAG

miRNA Target Type

Direct

Experimental Material

Human embryonic kidney 293 cells (HEK293)
References
1 Atypical Teratoid/Rhabdoid Tumors Are Comprised of Three Epigenetic Subgroups with Distinct Enhancer Landscapes. Cancer Cell. 2016 Mar 14;29(3):379-393.
2 DNA Methylation Dynamics in Urological Tumors.
3 Genome-wide Scan for Methylation Profiles in Breast Cancer
4 A CpG-methylation-based assay to predict survival in clear cell renal cell carcinoma. Nat Commun. 2015 Oct 30;6:8699.
5 Genome-scale analysis of DNA methylation in colorectal cancer using Infinium HumanMethylation450 BeadChips. Epigenetics. 2013 Sep;8(9):921-34.
6 Differences in DNA methylation signatures reveal multiple pathways of progression from adenoma to colorectal cancer. Gastroenterology. 2014 Aug;147(2):418-29.e8.
7 DNA methylation and inflammation marker profiles associated with a history of depression. Hum Mol Genet. 2018 Aug 15;27(16):2840-2850.
8 Exploring genome-wide DNA methylation profiles altered in hepatocellular carcinoma using Infinium HumanMethylation 450 BeadChips. Epigenetics. 2013 Jan;8(1):34-43.
9 HIV-1 Infection Accelerates Age According to the Epigenetic Clock. J Infect Dis. 2015 Nov 15;212(10):1563-73.
10 DNA methylation analysis of lung adenocarcinoma and adjacent non-tumor tissues
11 DNA Methylation signatures in panic disorder. Transl Psychiatry. 2017 Dec 18;7(12):1287.
12 Prognostic Classifier Based on Genome-Wide DNA Methylation Profiling in Well-Differentiated Thyroid Tumors. J Clin Endocrinol Metab. 2017 Nov 1;102(11):4089-4099.
13 Genome-wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT-ROBO, ITGA2 and MET signaling. Int J Cancer. 2014 Sep 1;135(5):1110-8.
14 The methylome of the celiac intestinal epithelium harbours genotype-independent alterations in the HLA region. Mol Ther Oncolytics. 2019 Feb 5;12:235-245.
15 Reducing the risk of false discovery enabling identification of biologically significant genome-wide methylation status using the HumanMethylation450 array. BMC Genomics. 2014 Jan 22;15:51.
16 Genome-wide DNA methylation analysis of systemic lupus erythematosus reveals persistent hypomethylation of interferon genes and compositional changes to CD4+ T-cell populations. PLoS Genet. 2013;9(8):e1003678.
17 MiR-pharmacogenetics of methotrexate in childhood B-cell acute lymphoblastic leukemia. Pharmacogenet Genomics. 2016 Nov;26(11):517-525.
18 Hypermethylation of protocadherin subfamily A12 and solute carrier family 19 A 1 promoters contributes to the occurrence and metastasis of colorectal cancer. Oncol Lett. 2018 Jun;15(6):8215-8222.
19 Mapping the human miRNA interactome by CLASH reveals frequent noncanonical binding. Cell. 2013 Apr 25;153(3):654-65.
20 Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates. Genes Dev. 2013 Jul 15;27(14):1624-32.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.